Short-term orlistat treatment does not affect mineral balance and bone turnover in obese men. [electronic resource]
Producer: 20010628Description: 1694-9 p. digitalISSN:- 0022-3166
- Adult
- Anti-Obesity Agents -- pharmacology
- Bone and Bones -- metabolism
- Dietary Fats -- administration & dosage
- Double-Blind Method
- Electrolytes -- blood
- Energy Intake
- Enzyme Inhibitors -- pharmacology
- Feces -- chemistry
- Gastrointestinal Diseases -- chemically induced
- Humans
- Lactones -- adverse effects
- Male
- Minerals -- analysis
- Obesity -- drug therapy
- Orlistat
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.